Free radical-mediated oxidative DNA damage in the mechanism of thalidomide teratogenicity
The DOI matches its Crossref record; 24 of the 25 references it cites were found in a registry or an index.
Abstract
The sedative drug thalidomide ([+]-alpha-phthalimidoglutarimide), once abandoned for causing birth defects in humans, has found new therapeutic license in leprosy and other diseases, with renewed teratological consequences. Although the mechanism of teratogenesis and determinants of risk remain unclear, related teratogenic xenobiotics are bioactivated by embryonic prostaglandin H synthase (PHS) to a free-radical intermediates that produce reactive oxygen species (ROS), which cause oxidative damage to DNA and other cellular macromolecules. Similarly, thalidomide is bioactivated by horseradish peroxidase, and oxidizes DNA and glutathione, indicating free radical-mediated oxidative stress. Furthermore, thalidomide teratogenicity in rabbits is reduced by the PHS inhibitor acetylsalicylic acid, indicating PHS-catalyzed bioactivation. Here, we show in rabbits that thalidomide initiates embryonic DNA oxidation and teratogenicity, both of which are abolished by pre-treatment with the free radical spin trapping agent alpha-phenyl-N-t-butylnitrone (PBN). In contrast, in mice, a species resistant to thalidomide teratogenicity, thalidomide does not enhance DNA oxidation, even at a dose 300% higher than that used in rabbits, providing insight into an embryonic determinant of species-dependent susceptibility. In addition to their therapeutic implications, these results constitute direct evidence that the teratogenicity of thalidomide may involve free radical-mediated oxidative damage to em…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“They may cause direct cytotoxicity by inducing free radical mediated DNA damage.80”
From Multiple myeloma: 2024 update on diagnosis, risk-stratification, and management (2024) · cites this paper as [80]
Citations
Cites
8-Hydroxyguanine, an abundant form of oxidative DNA damage, causes G-T and A-C substitutions.
Cheng, K. C., Cahill, D. S., Kasai, H., Nishimura, S., & Loeb, L. A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)48474-8 · Cited by 1,844
A short history of thalidomide embryopathy
Lenz, W. (1988) · Teratology · doi:10.1002/tera.1420380303 · Cited by 784
Biochemical Toxicology of Chemical Teratogenesis
Wells, P. G., & Winn, L. M. (1996) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409239609110574 · Cited by 160
Self-citationThalidomide teratogenesis: evidence for a toxic arene oxide metabolite.
Gordon, G., Spielberg, S. P., Blake, D. A., & Balasubramanian, V. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2545 · Cited by 153
Schumacher, H., Smith, R. L., & Williams, R. T. (1965) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1965.tb02054.x · Cited by 144
Winn, L. M., & Wells, P. G. (1997) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(96)00340-1 · Cited by 129
Self-citationProposed mechanisms of action in thalidomide embryopathy
Stephens, T. D. (1988) · Teratology · doi:10.1002/tera.1420380307 · Cited by 111
Maternal administration of superoxide dismutase and catalase in phenytoin teratogenicity1
Winn, L. M., & Wells, P. G. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(98)00193-2 · Cited by 102
Self-citationFree Radical Intermediates of Phenytoin and Related Teratogens
Parman, T., Chen, G., & Wells, P. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25079 · Cited by 93
Self-citationCharacterization of a novel cytochrome P450 from the transformable cell line, C3H/10T1/2
Pottenger, L. H., & Jefcoate, C. R. E. (1990) · Carcinogenesis · doi:10.1093/carcin/11.2.321 · Cited by 88
Research works printed but not linked: 1
- Arlen, R.R. & Wells, P.G. Extracellular thiol-disulfide status reflecting chemical toxicity mediated via oxidative stress: Validation with paraquat and t-butylhydroperoxide and implications for phenytoin and thalidomide teratogenicity. FASEB J. 4, A608 (1990).
Cited by
Items 101–200 of 535
Antioxidants attenuate multiple phases of formalin-induced nociceptive response in mice
Hacımüftüoğlu, A., Handy, C., Goettl, V. M., LIN, C., Dane, Ş., & STEPHENSJR, R. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.06.030 · Cited by 105
Thalidomide in the management of multiple myeloma
Barlogie, B., Zangari, M., Spencer, T., Fassas, A., Anaissie, E. J., Badros, A., Cromer, J., & Tricot, G. J. K. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90017-4 · Cited by 103
Defoort, E. N., Kim, P. M., & Winn, L. M. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.017855 · Cited by 101
Thalidomide–A Notorious Sedative to a Wonder Anticancer Drug
Zhou, S. Y., Wang, F., Hsieh, T.-C., WU, J. M., & Wu, E. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990198 · Cited by 101
Meganathan, K., Jagtap, S., Wagh, V., Winkler, J., Gaspar, J. A., Hildebrand, D., Trusch, M., Lehmann, K., Hescheler, J., Schlüter, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044228 · Cited by 97
Peroxidases: a role in the metabolism and side effects of drugs
Tafazoli, S., & O'Brien, P. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03394-5 · Cited by 97
Meyring, M., Chankvetadze, B., & Blaschke, G. (2000) · Journal of Chromatography A · doi:10.1016/s0021-9673(00)00156-4 · Cited by 96
Oxidant damage to DNA and pregnancy outcome
Scholl, T. O., & Stein, T. P. (2001) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/714904323 · Cited by 95
Efficacy and safety of thalidomide in patients with acute myeloid leukemia
Steins, M. B., Padró, T., Bieker, R., Ruiz, S., Kropff, M. H., Kienast, J., Keßler, T., Büchner, T., Berdel, W. E., & Mesters, R. M. (2002) · Blood · doi:10.1182/blood.v99.3.834 · Cited by 95
Colla, S., Zhan, F., Xiong, W., Wu, X., Xu, H., Stephens, O., Yaccoby, S., Epstein, J., Barlogie, B., & Shaughnessy, J. D. (2007) · Blood · doi:10.1182/blood-2006-11-056747 · Cited by 89
Redox control of teratogenesis
Hansen, J. M., & Harris, C. (2012) · Reproductive Toxicology · doi:10.1016/j.reprotox.2012.09.004 · Cited by 93
Methamphetamine-enhanced embryonic oxidative DNA damage and neurodevelopmental deficits
Jeng, W., Wong, A. W., Ting‐A‐Kee, R. A., & Wells, P. G. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.015 · Cited by 91
Self-citationImmune tolerance: mechanisms and application in clinical transplantation
Sykes, M. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01855.x · Cited by 91
Thalidomide and its derivatives: emerging from the wilderness
Gordon, J., & Goggin, P. M. (2003) · Postgraduate Medical Journal · doi:10.1136/pmj.79.929.127 · Cited by 91
Molecular Mechanisms of the Teratogenic Effects of Thalidomide
Asatsuma‐Okumura, T., Ito, T., & Handa, H. (2020) · Pharmaceuticals · doi:10.3390/ph13050095 · Cited by 90
Hansen, J. M., Gong, S., Philbert, M. A., & Harris, C. (2002) · Developmental Dynamics · doi:10.1002/dvdy.10150 · Cited by 90
Oxidative Stress Mediated Idiosyncratic Drug Toxicity
Tafazoli, S., Spehar, D., & O'Brien, P. J. (2005) · Drug Metabolism Reviews · doi:10.1081/dmr-55227 · Cited by 90
Enomoto, N., Takei, Y., Hirose, M., Ikejima, K., Miwa, H., Kitamura, T., & Sato, N. (2002) · Gastroenterology · doi:10.1053/gast.2002.34161 · Cited by 90
Immunotherapy via PD-L1–presenting biomaterials leads to long-term islet graft survival
Coronel, M. M., Martin, K. E., Hunckler, M. D., Barber, G., O’Neill, E. B., Medina, J. D., Opri, E., McClain, C. A., Batra, L., Weaver, J. D., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba5573 · Cited by 89
“Tolerance induction has been hypothesized to require a reduction in the clonal size of the effector population for alloantigens to a level that can be controlled through anergy and/or immunoregulation over time (46).”
BackgroundYamanaka, S., Murai, H., Saito, D., Abe, G., Tokunaga, E., Iwasaki, T., Takahashi, H., Takeda, H., Suzuki, T., Shibata, N., et al. (2021) · The EMBO Journal · doi:10.15252/embj.2020105375 · Cited by 89
Pathogenesis of Diabetes-Induced Congenital Malformations
Eriksson, U. J., Borg, L., Cederberg, J., Nordstrand, H., Simán, C. M., Wentzel, C., & Wentzel, P. (2000) · Upsala Journal of Medical Sciences · doi:10.1517/03009734000000055 · Cited by 89
Cathepsin D and H2O2 Stimulate Degradation of Thioredoxin-1
Haendeler, J., Popp, R., Goy, C., Tischler, V., Zeiher, A. M., & Dimmeler, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506985200 · Cited by 88
Xu, D., Chen, Y., Wang, H., Zhao, L., Wang, J., & Wei, W. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi300 · Cited by 88
Free radicals and birth defects
Loeken, M. R. (2004) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767050310001650662 · Cited by 88
Pharmacologic Properties of Phenyl N-tert -Butylnitrone
Kotake, Y. (1999) · Antioxidants & Redox Signaling · doi:10.1089/ars.1999.1.4-481 · Cited by 84
Lan, N., Wartenberg, M., Nau, H., Hescheler, J., & Sauer, H. (2003) · Birth Defects Research Part A Clinical and Molecular Teratology · doi:10.1002/bdra.10030 · Cited by 85
DNA repair during organogenesis
Vinson, R. K., & Hales, B. F. (2002) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(02)00223-3 · Cited by 83
Thalidomide in multiple myeloma: current status and future prospects
Cavenagh, J. D., Oakervee, H. E., & Forces, O. B. O. T. U. M. F. A. T. B. H. T. (2002) · British Journal of Haematology · doi:10.1046/j.1365-2141.2003.03902.x · Cited by 82
Roles of cytokines in the pathogenesis and therapy of type 1 diabetes
Rabinovitch, A., & Suarez‐Pinzon, W. L. (2007) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-007-0029-2 · Cited by 81
Receptor- and Reactive Intermediate-Mediated Mechanisms of Teratogenesis
Wells, P. G., Lee, C. J. J., McCallum, G. P., Perstin, J., & Harper, P. A. (2009) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-00663-0_6 · Cited by 80
Self-citationHumanized cereblon mice revealed two distinct therapeutic pathways of immunomodulatory drugs
Gemechu, Y., Millrine, D., Hashimoto, S., Prakash, J., Sanchenkova, K., Metwally, H., Gyanu, P., Kang, S., & Kishimoto, T. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1814446115 · Cited by 78
Recent advances in the molecular mechanism of thalidomide teratogenicity
Gao, S., Wang, S., Fan, R., & Hu, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110114 · Cited by 78
Nitrones, their value as therapeutics and probes to understand aging
Floyd, R. A., Hensley, K., Forster, M. J., Kelleher-Andersson, J. A., & Wood, P. L. (2002) · Mechanisms of Ageing and Development · doi:10.1016/s0047-6374(01)00385-2 · Cited by 78
Hawk, S. N., Lanoue, L., Keen, C. L., Kwik-Uribe, C. L., Rucker, R. B., & Uriu‐Adams, J. Y. (2003) · Biology of Reproduction · doi:10.1095/biolreprod.102.009167 · Cited by 78
Jalkanen, K. J., Jürgensen, V. W., Claussen, A., Rahim, A., Jensen, G. M., Wade, R. C., Nardi, F., Jung, C., Degtyarenko, I. M., Nieminen, R. M., et al. (2005) · International Journal of Quantum Chemistry · doi:10.1002/qua.20863 · Cited by 78
Thalidomide Embryopathy: An Enigmatic Challenge
Vargesson, N. (2013) · ISRN Developmental Biology · doi:10.1155/2013/241016 · Cited by 62
Knobloch, J., Schmitz, I., Götz, K., Schulze‐Osthoff, K., & Rüther, U. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.00553-07 · Cited by 74
Johnson, D. C., Corthals, S. L., Ramos, C., Hoering, A., Cocks, K., Dickens, N. J., Haessler, J., Goldschmidt, H., Child, J. A., Bell, S., et al. (2008) · Blood · doi:10.1182/blood-2008-02-140434 · Cited by 73
Hansen, J. M., Harris, K. K., Philbert, M. A., & Harris, C. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.768 · Cited by 73
Thalidomide: history, withdrawal, renaissance, and safety concerns
Vargesson, N., & Stephens, T. D. (2021) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2021.1991307 · Cited by 72
(2012) · Molecular and Cellular Biology · doi:10.1128/mcb.05712-11 · Cited by 72
The Redox Theory of Development
Hansen, J. M., Jones, D. P., & Harris, C. (2019) · Antioxidants and Redox Signaling · doi:10.1089/ars.2019.7976 · Cited by 72
Deciphering the mystery of thalidomide teratogenicity
Ito, T., & Handa, H. (2011) · Congenital Anomalies · doi:10.1111/j.1741-4520.2011.00351.x · Cited by 71
Reactive Oxygen Species Contribute to Lipopolysaccharide-Induced Teratogenesis in Mice
Zhao, L., Chen, Y., Wang, H., Ji, Y., Ning, H., Wang, S., Zhang, C., Lu, J.-W., Duan, Z.-H., & Xu, D. (2008) · Toxicological Sciences · doi:10.1093/toxsci/kfn027 · Cited by 70
Theoretical Basis for the Activity of Thalidomide
Meierhofer, C., Dunzendorfer, S., & Wiedermann, C. J. (2001) · BioDrugs · doi:10.2165/00063030-200115100-00005 · Cited by 70
Thalidomide on the comeback trail
Hales, B. F. (1999) · Nature Medicine · doi:10.1038/8371 · Cited by 70
Nitrone-Related Therapeutics: Potential of NXY-059 for the Treatment of Acute Ischaemic Stroke
Maples, K. R., Green, A. R., & Floyd, R. A. (2004) · CNS Drugs · doi:10.2165/00023210-200418150-00003 · Cited by 67
Testing of new agents in childhood cancer preclinical models: meeting summary.
Houghton, P. J., Adamson, P. C., Blaney, S. M., Fine, H. A., Gorlick, R. G., Haber, M., Helman, L. J., Hirschfeld, S., Hollingshead, M. G., Israel, M. A., et al. (2002) · PubMed · Cited by 67
The role of the tumor microenvironment in hematological malignancies and implication for therapy
Zhou, J. (2005) · Frontiers in bioscience · doi:10.2741/1642 · Cited by 67
Schey, S., Cavenagh, J. D., Johnson, R. J., Child, J. A., Oakervee, H. E., & Jones, R. W. (2003) · Leukemia Research · doi:10.1016/s0145-2126(03)00027-4 · Cited by 66
Thioredoxin-1 and Endothelial Cell Aging: Role in Cardiovascular Diseases
Altschmied, J., & Haendeler, J. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2379 · Cited by 65
Genetic Advances in the Understanding of Microtia
Gendron, C., Schwentker, A. R., & van Aalst, J. A. (2016) · Journal of Pediatric Genetics · doi:10.1055/s-0036-1592422 · Cited by 65
Serendipity in Cancer Drug Discovery: Rational or Coincidence?
Prasad, S., Gupta, S. C., & Aggarwal, B. B. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.03.004 · Cited by 64
Thalidomide: an old drug with new clinical applications
Laffitte, E., & Revuz, J. E. (2004) · Expert Opinion on Drug Safety · doi:10.1517/14740338.3.1.47 · Cited by 64
Antimyeloma efficacy of thalidomide in the SCID-hu model
Yaccoby, S., Johnson, C. L., Mahaffey, S., Wezeman, M. J., Barlogie, B., & Epstein, J. (2002) · Blood · doi:10.1182/blood-2002-03-0939 · Cited by 63
Heterogeneity of Toxicant Response: Sources of Human Variability
Aldridge, J. E., Gibbons, J. A., Flaherty, M. M., Kreider, M. L., Romano, J. A., & Levin, E. D. (2003) · Toxicological Sciences · doi:10.1093/toxsci/kfg204 · Cited by 63
Molecular analysis of point mutations in a barley genome exposed to MNU and gamma rays
Kurowska, M. M., Labocha-Pawłowska, A., Gnizda, D., Małuszyński, M., & Szarejko, I. (2012) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2012.08.008 · Cited by 61
Arsenate-induced maternal glucose intolerance and neural tube defects in a mouse model
Hill, D. S., Wlodarczyk, B. J., Mitchell, L. E., & Finnell, R. H. (2009) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2009.05.009 · Cited by 60
Wells, P. G., Bhatia, S., Drake, D. M., & Miller‐Pinsler, L. (2016) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21134 · Cited by 60
Self-citationOxidative stress and DNA damage in the mechanism of fetal alcohol spectrum disorders
Bhatia, S., Drake, D. M., Miller, L., & Wells, P. G. (2019) · Birth Defects Research · doi:10.1002/bdr2.1509 · Cited by 60
Self-citationAvigdor, A., Raanani, P., Levi, I., Hardan, I., & Ben‐Bassat, I. (2001) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428190109099330 · Cited by 60
Cereblon in health and disease
Kim, H. K., Ko, T. H., Nyamaa, B., Lee, S. R., Kim, N., Ko, K. S., Rhee, B. D., Park, C., Nilius, B., & Han, J. (2016) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-016-1854-1 · Cited by 58
Johnston, R. E., & Abdalla, S. (2002) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190290006143 · Cited by 58
Meyring, M., Mühlbacher, J., Messer, K., Pustet, N., Bringmann, G., Mannschreck, A., & Blaschke, G. (2002) · Analytical Chemistry · doi:10.1021/ac0203138 · Cited by 57
Parman, T., & Wells, P. G. (2002) · The FASEB Journal · doi:10.1096/fj.01-0140com · Cited by 57
Self-citationCereblon negatively regulates TLR4 signaling through the attenuation of ubiquitination of TRAF6
Min, Y., Wi, S. M., Kang, J., Yang, T., Park, C., Park, S., Chung, S., Shim, J., Chun, E., & Lee, K. (2016) · Cell Death and Disease · doi:10.1038/cddis.2016.226 · Cited by 56
The status of diabetic embryopathy
Eriksson, U. J., & Wentzel, P. (2016) · Upsala Journal of Medical Sciences · doi:10.3109/03009734.2016.1165317 · Cited by 55
Puskás, L. G., Fehér, L. Z., Vízler, C., Ayaydin, F., Rásó, E., Molnár, E., Magyary, I., Kanizsai, I., Gyuris, M., Madácsi, R., et al. (2010) · Lipids in Health and Disease · doi:10.1186/1476-511x-9-56 · Cited by 55
Chong, L., Hsu, Y., Chiu, Y.-T., Yang, K., & Huang, Y. (2006) · Journal of Biomedical Science · doi:10.1007/s11373-006-9079-5 · Cited by 55
Sivakumar, S., & Subramanian, S. P. (2009) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2009.09.021 · Cited by 53
Brown, R. D., Spencer, A., Joy Ho, P., Kennedy, N., Kabani, K., Yang, S., Sze, D. M., Aklilu, E., Gibson, J., & Joshua, D. E. (2009) · Leukemia & Lymphoma · doi:10.3109/10428190903216804 · Cited by 49
Enantiomerization Mechanism of Thalidomide and the Role of Water and Hydroxide Ions
Tian, C., Xiu, P., Yan, M., Zhao, W., Wang, Z., & Zhou, R. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201202651 · Cited by 52
Chowdhury, G., Murayama, N., Okada, Y., Uno, Y., Shimizu, M., Shibata, N., Guengerich, F. P., & Yamazaki, H. (2010) · Chemical Research in Toxicology · doi:10.1021/tx900367p · Cited by 52
Rahman, M. L., Valeri, L., Kile, M. L., Mazumdar, M., Mostofa, G., Qamruzzaman, Q., Rahman, M., Baccarelli, A., Liang, L., Hauser, R. B., et al. (2017) · Environment International · doi:10.1016/j.envint.2017.07.026 · Cited by 52
Durand, G., Choteau, F., Pucci, B., & Villamena, F. A. (2008) · The Journal of Physical Chemistry A · doi:10.1021/jp804929d · Cited by 51
Penna, G. O., Martelli, C. M. T., Stefani, M. M. A., Macêdo, V. O., Marója, M. D. F., & Chaul, A. (2005) · Anais Brasileiros de Dermatologia · doi:10.1590/s0365-05962005000600010 · Cited by 50
Targeted therapy for multiple myeloma
Anderson, K. C. (2001) · Seminars in Hematology · doi:10.1016/s0037-1963(01)90021-6 · Cited by 50
Oxidative stress mediates thalidomide-induced pain by targeting peripheral TRPA1 and central TRPV4
Logu, F. D., Trevisan, G., Marone, I. M., Coppi, E., Dalenogare, D. P., Titiz, M., Marini, M., Landini, L., de Araújo, D. S. M., Puma, S. L., et al. (2020) · BMC Biology · doi:10.1186/s12915-020-00935-9 · Cited by 49
Hansen, J. M., Carney, E. W., & Harris, C. (1999) · Reproductive Toxicology · doi:10.1016/s0890-6238(99)00053-2 · Cited by 49
Schütt, P., Ebeling, P. R., Buttkereit, U., Brandhorst, D., Opalka, B., Hoiczyk, M., Flaßhove, M., Hense, J., Bojko, P., Metz, K. A., et al. (2004) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00349.x · Cited by 49
Tseng, J. E., Glisson, B. S., Khuri, F. R., Shin, D. M., Myers, J. N., El‐Naggar, A. K., Roach, J. S., Ginsberg, L. E., Thall, P. F., Wang, X., et al. (2001) · Cancer · doi:10.1002/1097-0142(20011101)92:9<2364::aid-cncr1584>3.0.co;2-p · Cited by 49
Thalidomide-induced limb abnormalities in a humanized CYP3A mouse model
Kazuki, Y., Akita, M., Kobayashi, K., Osaki, M., Satoh, D., Ohta, R., Abe, S., Takehara, S., Kazuki, K., Yamazaki, H., et al. (2016) · Scientific Reports · doi:10.1038/srep21419 · Cited by 48
Thalidomide as an Immunotherapeutic Agent: The Effects on Neutrophil- Mediated Inflammation
Yasui, K., Kobayashi, N., Yamazaki, T., & Agematsu, K. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053382179 · Cited by 48
Teratogen screening using transcriptome profiling of differentiating human embryonic stem cells
Mayshar, Y., Yanuka, O., & Benvenisty, N. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01105.x · Cited by 47
Prenatal exposure to environmental factors and congenital limb defects
Alexander, P. G., Clark, K. L., & Tuan, R. S. (2016) · Birth Defects Research Part C Embryo Today Reviews · doi:10.1002/bdrc.21140 · Cited by 47
Multiple myeloma cells’ capacity to decompose H2O2 determines lenalidomide sensitivity
Sebastian, S., Zhu, Y. X., Braggio, E., Shi, C.-X., Panchabhai, S. C., Wier, S. A. V., Ahmann, G. J., Chesi, M., Bergsagel, P. L., Stewart, A. K., et al. (2016) · Blood · doi:10.1182/blood-2016-09-738872 · Cited by 47
Yamazaki, H., Suemizu, H., Shimizu, M., Igaya, S., Shibata, N., Nakamura, M., Chowdhury, G., & Guengerich, F. P. (2012) · Chemical Research in Toxicology · doi:10.1021/tx300009j · Cited by 46
Miller‐Pinsler, L., Pinto, D. J., & Wells, P. G. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.09.026 · Cited by 46
Self-citationYamazaki, H., Suemizu, H., Mitsui, M., Shimizu, M., & Guengerich, F. P. (2016) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.6b00136 · Cited by 46
Lee, C. J. J., Gonçalves, L. M. L., & Wells, P. G. (2011) · The FASEB Journal · doi:10.1096/fj.10-178814 · Cited by 46
Self-citationTeratogens inducing congenital abdominal wall defects in animal models
Dorp, D. R. V., Malleis, J. M., Sullivan, B. P., & Klein, M. D. (2009) · Pediatric Surgery International · doi:10.1007/s00383-009-2482-z · Cited by 45
Thalidomide Resistance Is Based on the Capacity of the Glutathione-Dependent Antioxidant Defense
Knobloch, J., Reimann, K., Klotz, L., & Rüther, U. (2008) · Molecular Pharmaceutics · doi:10.1021/mp8001232 · Cited by 44
Sampaio, E. P., Hernandez, M. O., de Carvalho, D. S., & Sarno, E. N. (2002) · Biomedicine & Pharmacotherapy · doi:10.1016/s0753-3322(01)00147-0 · Cited by 44
The Dihydroxy Metabolite of the Teratogen Thalidomide Causes Oxidative DNA Damage
Wani, T. H., Chakrabarty, A., Shibata, N., Yamazaki, H., Guengerich, F. P., & Chowdhury, G. (2017) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.7b00127 · Cited by 43
Kobayashi‐Miura, M., Shioji, K., Hoshino, Y., Masutani, H., Nakamura, H., & Yodoi, J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01316.2006 · Cited by 43
Winn, L. M., Kim, P. M., & Nickoloff, J. A. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052639 · Cited by 43
Li, C., Zhang, R., Sogore, T., Feng, J., Liao, X., Wang, X., Zhang, Z., & Ding, T. (2025) · Sustainable Food Technology · doi:10.1039/d5fb00006h · Cited by 42
N rf2‐Mediated Resistance to Oxidant‐Induced Redox Disruption in Embryos
Harris, C., & Hansen, J. M. (2012) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.21005 · Cited by 42
Redox mechanisms of environmental toxicants on male reproductive function
Hussain, T., Metwally, E., Murtaza, G., Kalhoro, D. H., Chughtai, M. I., Tan, B., Ömür, A. D., Tunio, S. A., Akbar, M., & Kalhoro, M. S. (2024) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2024.1333845 · Cited by 40
Natural killer T cells expressing IFN‐γ and IL‐4 in lesional skin of atopic eczema
Simon, D., Kozlowski, E., & Simon, H. (2009) · Allergy · doi:10.1111/j.1398-9995.2009.02097.x · Cited by 40
Metadata
- Authors
- Parman, T., Wiley, M. J., & Wells, P. G.
- Affiliations
- University of Toronto (CA)
- Corresponding author
- Wells, Peter G.
- ORCID
- Wells, Peter G.
- Venue
- Nature Medicine
- Published
- 1999-05
- Volume
- 5
- Issue
- 5
- Pages
- 582-585
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- DOI
- 10.1038/8466
- OpenAlex
- W1568733499
- Semantic Scholar
- 584f5e94f837063f4ceb1b3ddec9c4c9c9ed44ff
- Cited by
- 495
- References
- 25
- Citations by year
- 2026: 4 · 2025: 7 · 2024: 11 · 2023: 2 · 2022: 10 · 2021: 12 · 2020: 10 · 2019: 14 · 2018: 14 · 2017: 10 · 2016: 18 · 2015: 19 · 2014: 13 · 2013: 19 · 2012: 19
- FWCI
- 32.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Pharmacological Effects and Toxicity Studies
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Redox biology and oxidative stress
- Keywords
- thalidomide, teratogenicity, oxidative DNA damage, free radicals, reactive oxygen species, prostaglandin H synthase, horseradish peroxidase, glutathione oxidation, spin trapping, aspirin, embryonic development, congenital malformations
- MeSH terms
- Animals, Cyclic N-Oxides, DNA Damage, Drug Resistance, Embryo, Mammalian, Female, Free Radicals, Hernia, Umbilical, Hypnotics and Sedatives, Nitrogen Oxides, Oxidation-Reduction, Pregnancy, Rabbits, Species Specificity, Teratogens, Thalidomide, Free Radical Scavengers, Limb Deformities, Congenital, Embryo Loss, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.